Pelitinib (EKB-569) ≥97.0% (by HPLC)
Proveedor: TCI
|
Peligro
|
Sinónimos:
(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide, (E)-N-(4-(3-chloro-4-fluorophenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide, EKB 569, Pelitinib, (2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-dimethylamino-2-butenamide
P2529-25MG
P2529-100MG
TCIAP2529-25MGEA
78
EUR
TCIAP2529-25MG
TCIAP2529-100MG
Pelitinib (EKB-569) ≥97.0% (by HPLC)
Pelitinib (EKB-569)
Formula:
C₂₄H₂₃ClFN₅O₂ MW: 467,92 g/mol Pto. de fusión: 198°C Temperatura de almacenaje: Congelador |
Número MDL:
MFCD09837868 Núm. CAS: 257933-82-7 UN: 2811 ADR: 6.1,III |
Resultados test especificaciones
Appearance | White to Light yellow powder to crystal |
Purity (HPLC) | min. 97.0 area% |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...